Novo Nordisk's $10B Metsera Bid: Not Just a Deal, It's a Glimpse into the Future of Personalized Health Okay, folks, buckle up. Because what's happening with Novo Nordisk (NVO) and Metsera (MTSR) isn’t just another corporate acquisition—it’...